The “Mycoplasma Testing Market by Product & Services, Technique, Application, and End User – Global Forecast to 2022” report has been added to Research and Markets’ offering.
The global mycoplasma testing market is expected to reach USD 943.4 million by 2022, at a CAGR of 12.5% from 2017 to 2022
The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination. On the other hand, the growth of this market is hindered to some extent due to the stringent regulatory framework & time-consuming approval processes and the high degree of consolidation which acts as an entry barrier for new companies.
On the basis of products, the mycoplasma testing market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to grow at a higher rate during the forecast period. This is attributed to the frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques.
Based on end users, the mycoplasma testing market is segmented into pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), cell banks, and other end users. In 2017, pharmaceutical and biotechnology companies segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to the other segments. This can be attributed to the increasing R&D investments in the pharmaceutical industry.
Asia is estimated to be the fastest growing regional segment in the global mycoplasma testing market during the forecast period.
Key Topics Covered:
3 Executive Summary
4 Mycoplasma Testing Market: Premium Insights
5 Market Overview
6 Mycoplasma Testing Market, By Product & Service
7 Mycoplasma Testing Market, By Technique
8 Mycoplasma Testing Market, By Application
9 Mycoplasma Testing Market, By End User
10 Geographic Analysis
11 Competitive Landscape
12 Company Profiles
– Charles River Laboratories International, Inc.
– Merck KGaA
– Lonza Group Ltd.
– Roche Diagnostics (Division of F. Hoffman-LA Roche Ltd.)
– SGS S.A.
– Thermo Fisher Scientific Inc.
– American Type Culture Collection
– Biounique Testing Laboratories Inc.
– Promocell GmbH
– Biological Industries Israel Beit Haemek Ltd.
– Wuxi Apptec
– Norgen Biotek Corporation
For more information about this report visit https://www.researchandmarkets.com/research/4lh7fm/mycoplasma